杨浩,孔高茵,阳颖,王逸伦,凌英姿,潘冰冰.布托啡诺经鼻给药对全麻诱导期舒芬太尼诱发呛咳反应的预防作用.[J].中南医学科学杂志.,2023,(2):210-213.
布托啡诺经鼻给药对全麻诱导期舒芬太尼诱发呛咳反应的预防作用
Preventive effect of butorphanol nasal administration on sufentanil induced cough response during induction of general anesthesia
投稿时间:2022-11-10  修订日期:2023-01-28
DOI:10.15972/j.cnki.43-1509/r.2023.02.013
中文关键词:  布托啡诺  舒芬太尼  全身麻醉  呛咳  经鼻给药 [
英文关键词:butorphanol  sufentanil  general anesthesia  choking cough  nasal dministration
基金项目:湖南省卫生健康委科研项目(202104111604);湖南省围术期加速康复麻醉临床医学研究中心资助项目(2018SK7001)
作者单位E-mail
杨浩 湖南师范大学湖南长沙410005
湖南省人民医院湖南师范大学附属第一医院麻醉科湖南长沙410005 
e-mail为542755231@qq.com,e-mail为iceblue0619@126.com 
孔高茵 湖南省人民医院湖南师范大学附属第一医院麻醉科湖南长沙410005
湖南省围术期加速康复麻醉临床医学研究中心湖南长沙 410005 
 
阳颖 湖南师范大学湖南长沙410005  
王逸伦 湖南省人民医院湖南师范大学附属第一医院麻醉科湖南长沙410005  
凌英姿 湖南省人民医院湖南师范大学附属第一医院麻醉科湖南长沙410005
湖南省围术期加速康复麻醉临床医学研究中心湖南长沙 410005 
 
潘冰冰 湖南省人民医院湖南师范大学附属第一医院麻醉科湖南长沙410005
湖南省围术期加速康复麻醉临床医学研究中心湖南长沙 410005 
e-mail为542755231@qq.com,e-mail为iceblue0619@126.com 
摘要点击次数: 140
全文下载次数: 134
中文摘要:
      目的探究布托啡诺经鼻给药对全麻诱导期舒芬太尼诱发呛咳反应的预防作用。 方法将择期手术患者120例均分为对照组(全麻诱导前2 min静脉注射生理盐水1 mL)、静脉注射组(全麻诱导前2 min静脉注射布托啡诺1 mg),经鼻低剂量组(全麻诱导前15 min经鼻给与布托啡诺1 mg),经鼻高剂量组(全麻诱导前15 min经鼻给与布托啡诺2 mg)。观察各组患者呛咳反应发生率及严重程度;监测各组患者生命体征、临床指标及术后不良事件的发生情况。 结果静脉注射组、经鼻低剂量组、经鼻高剂量组呛咳反应发生率低于对照组(P<0.05);患者全麻苏醒及术后不良事件差异无显著性(P>0.05)。 结论高剂量布托啡诺经鼻给药对舒芬太尼诱发的呛咳反应有预防作用,不影响患者全麻苏醒,且术后无不良事件。
英文摘要:
      AimTo investigate the preventive effect of butorphanol nasal administration on cough reaction induced by sufentanil during induction of general anesthesia. Methods120 patients undergoing elective surgery were randomly divided into the control group (1 mL saline was injected intravenously 2 minutes before induction of general anesthesia), the intravenous injection group (butorphanol 1 mg was injected intravenously 2 minutes before induction of general anesthesia), the low-dose nasal group (butorphanol 1 mg was administered intravenously 15 minutes before induction of general anesthesia), the high-dose nasal group (butorphanol 2 mg was administered intravenously 15 minutes before induction of general anesthesia). The incidence and severity of cough reactions in patients in each group were observed. Incidence of vital signs, clinical indicators, and postoperative adverse events in each group were monitored. ResultsThe incidence of choking reaction induced by sufentanil in the Intravenous group, Low-dose nasal group and High-dose nasal group was lower than that in Control group, and the difference was statistically significant (P<0.05). There was no significant difference in recovery from general anesthesia and postoperative adverse reactions (P>0.05). ConclusionNasal administration of butorphanol had a preventive effect on sufentanil-induced cough, did not affect the patient's recovery from general anesthesia, and there were no postoperative adverse events.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=318DFCB05C203DB60B558B387B613A5D8C7D1E50CBF9A5704AE4473E780221744202D03644255459C6AD9544655D5C9BF72AECEA05DBE967BF878659314E2A2B3D19FAE41352EA3CC6FE4311D68A28E5FE8D23FADD5672CB1C4FF591F914AF0DF1AF4B1EB827C9075507CDE90063412B5BC8E01ABF2AEF6B41943237BC73225F5CD4C4D3BE4E7511&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=BB33F1C95224820A&jid=6A20DF2A798996E24F064D5ECF83A153&yid=BA1E75DF0B7E0EB2&aid=B82D0CD8A3C3D1DB6F7FAD2C71F7C6F2&vid=&iid=0B39A22176CE99FB&sid=AA27B676BFCAA4BE&eid=527AEE9F3446633A&fileno=20230213&flag=1&is_more=0">